TALPHERA INC(NASDAQ:TLPH) stock News

TLPH Latest News, Press Relases and Analysis

All

Press Releases

22 days ago - By: Benzinga - Mentions: ZONE STKH JEM TRML ...

Why Nebius Group Shares Are Trading Higher By Around 50%; Here Are 20 Stocks Moving Premarket

2 months ago - By: The Motley Fool - Mentions: ACRX

Talphera Cuts Expenses 14 Percent

2 months ago - By: The Motley Fool - Mentions: ACRX

Talphera Cuts Costs and Speeds Trial

2 months ago - By: Benzinga

A Preview Of Talphera's Earnings

23 days ago - By: Talphera, Inc. - Mentions: CRMD

Talphera Announces Private Placement Financing of up to $29 Million Priced At-the Market

a month ago - By: Talphera, Inc.

Talphera Announces Achievement of 17 Patient Enrollment Milestone in NEPHRO CRRT Pivotal Trial

2 months ago - By: Talphera, Inc.

Talphera Announces Second Quarter 2025 Financial Results and Provides Corporate Update

2 months ago - By: Talphera, Inc.

Talphera to Host Second Quarter Financial Results and Corporate Update Call and Webcast on Thursday, August 14, 2025

5 months ago - By: Talphera, Inc.

Talphera Announces First Quarter 2025 Financial Results and Provides Corporate Update

5 months ago - By: Talphera, Inc.

Talphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 14, 2025

5 months ago - By: Zacks Investment Research

All You Need to Know About Talphera (TLPH) Rating Upgrade to Strong Buy

6 months ago - By: Talphera, Inc.

Talphera Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

6 months ago - By: Talphera, Inc.

Talphera Announces Agreement with the FDA to Reduce the NEPHRO CRRT Study Size to 70 Patients From 166 and a Private Placement Financing Priced At-the Market of up to $14.8 Million

6 months ago - By: Talphera, Inc.

Talphera to Host Fourth Quarter and Full-Year 2024 Financial Results and Corporate Update Call and Webcast on Monday, March 31, 2025

9 months ago - By: Talphera, Inc.

Talphera Announces Agreement with the FDA for Prior Approval Supplement Review to Reduce the Number of Patients in the NEPHRO CRRT Study

a year ago - By: Talphera, Inc.

Talphera Announces Third Quarter 2024 Financial Results and Provides Corporate Update

a year ago - By: Talphera, Inc.

TALPHERA INC (TLPH) Stock News

TLPH Latest News, Press Relases and Analysis

Why Nebius Group Shares Are Trading Higher By Around 50%; Here Are 20 Stocks Moving Premarket

Talphera Cuts Expenses 14 Percent

Talphera Cuts Costs and Speeds Trial

A Preview Of Talphera's Earnings

Talphera Announces Private Placement Financing of up to $29 Million Priced At-the Market

Talphera Announces Achievement of 17 Patient Enrollment Milestone in NEPHRO CRRT Pivotal Trial

Talphera Announces Second Quarter 2025 Financial Results and Provides Corporate Update

Talphera to Host Second Quarter Financial Results and Corporate Update Call and Webcast on Thursday, August 14, 2025

Talphera Announces First Quarter 2025 Financial Results and Provides Corporate Update

Talphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 14, 2025

All You Need to Know About Talphera (TLPH) Rating Upgrade to Strong Buy

Talphera Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Talphera Announces Agreement with the FDA to Reduce the NEPHRO CRRT Study Size to 70 Patients From 166 and a Private Placement Financing Priced At-the Market of up to $14.8 Million

Talphera to Host Fourth Quarter and Full-Year 2024 Financial Results and Corporate Update Call and Webcast on Monday, March 31, 2025

Talphera Announces Agreement with the FDA for Prior Approval Supplement Review to Reduce the Number of Patients in the NEPHRO CRRT Study

Talphera Announces Third Quarter 2024 Financial Results and Provides Corporate Update

Talphera to Host Third Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday, November 13, 2024